“Comparing The Safety And Efficacy Of Sitagliptin Vs Dapagliflozin And The Risk Of Hyperkalaemia Among People With Type 2 Diabetes Mellitus And Kidney Disease ”, VER, vol. 8, no. 9s, pp. 230–236, Nov. 2025, doi: 10.64149/J.Ver.8.9s.230-236.